Dystrophin expression in muscles of mdx mice after adenovirus-mediated in vivo gene transfer

Human Gene Therapy

Volumn 7, Issue 2, 1996, Pages 129-140

  Acsadi, Gyula ^a,d   Lochmüller, Hanns ^a   Jani, Agnes ^a,d   Huard, Johnny ^a   Massie, Bernard ^b   Prescott, Stephen ^a   Simoneau, Maude ^b   Petrof, Basil J ^c   Karpati, George ^a,e  

^a MCGILL UNIVERSITY   (Canada)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^c ROYAL VICTORIA HOSPITAL   (Canada)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; COMPLEMENTARY DNA; DYSTROPHIN;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOTOXIC LYMPHOCYTE; DIAPHRAGM; GENE TRANSFER; GENETIC TRANSDUCTION; HEART LEFT VENTRICLE; INTERCOSTAL MUSCLE; MICROSCOPY; MUSCLE CELL; MUSCLE INJURY; MUSCULAR DYSTROPHY; NONHUMAN; PROMOTER REGION; ROUS SARCOMA ONCOVIRUS; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALIA; CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; ONCOVIRINAE; ROUS SARCOMA VIRUS;

EID: 0030066219     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.2-129     Document Type: Article

References (48)

1. ACSADI, G., DICKSON, G., LOVE, D., JANI, A., GURUSINGHE, A., WALSH, F.S., WOLFF, J.A., and DAVIES, K.E. (1991). Human dystrophin expression in mdx mice after injection of DNA constructs. Nature 352, 815-818.
2. ACSADI, G., JANI, A., HUARD, J., BLASCHUK, K., MASSIE, B., HOLLAND, P., LOCHMÜLLER, H., and KARPATI, G. (1994a). Cultured human myoblasts and myotubes show markedly different transducibility by replication-defective adenovirus recombinants. Gene Ther. 1, 338-340.
3. ACSADI, G., JANI, A., MASSIE, B., SIMONEAU, M., HOLLAND, P., BLASCHUK, K., and KARPATI, G. (1994b). A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity. Hum. Mol. Genet. 3, 579-584.
4. + suppressor cells. Ann. Neurol. 23, 493-499.
5. AUSUBEL, F.M., BRENT, R., KINGSTON, R.E., MOORE, D.D., SEIDMAN, J.G., SMITH, J.A., and STRUHL, K., eds. (1992). In Short Protocols in Molecular Biology, 2nd ed. (John Wiley & Sons, New York).
6. BOSMA, G.C., CUSTER, P., and BOSMAL, M.J. (1983). A severe combined immunodeficiency mutation in the mouse. Nature 301, 527-530.
7. BULFIELD, G., SILLER, W.G., WIGHT, P.A.L., and MOORE, K.J. (1984). X-chromosome-linked muscular dystrophy (MDX) in the mouse. Proc. Natl. Acad. Sci. USA 81, 1189-1192.
8. CHROBOCZEK, J., and JACROT, B. (1987). The sequence of the genome of adenovirus type 5 and its comparison with the genome of adenovirus type 1. Virology 161, 549-554.
9. COX, G.A., COLE, N.M., KATSUMARA, K., PHELPS, S.F., HAUSCHKA, S., CAMPBELL, K.P., FAULKNER, J.A., and CHAMBERLAIN, J.P. (1993). Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity. Nature 364, 725-729.
10. DANKO, I., FRITZ, J.D., LANTENDRESSE, J.S., HERWIJER, H., SCHULTZ, E., and WOLFF, J.A. (1993). Dystrophin expression improves myofiber survival in mdx muscle following intramuscular plasmid DNA injection. Hum. Mol. Genet. 2, 2055-2061.
11. DUNCKLEY, M.G., LOVE, D.R., DAVIES, K.E., WALSH, F.S., MORRIS, G.E., and DICKSON, G. (1992). Retroviral-mediated transfer of a dystrophin minigene into mdx mouse myoblasts in vitro. FEBS Lett. 296, 128-134.
12. ENGEL, A.G., and ARAHATA, K. (1986). Mononuclear cells in myopathies. Quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases and implications for the pathogenesis of the different inflammatory myopathies. Human Pathol. 17, 704-721.
13. ENGEL, A.G., ARAHATA, K., and EMSLIE-SMITH, A.M. (1990). Immune effector mechanisms in inflammatory myopathies. Res. Publ. Assoc. Res. Nerv. Ment. Dis. 68, 141-157.
14. ENGLAND, S.B., NICHOLSON, L.V.B., JOHNSON, M.A., FORREST, S.M., LOVE, D.R., ZUBRZYZCKA-GAARN, E.E., BULMAN, D.E., HARRIS, J.B., and DAVIES, J.E. (1990). Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature 343, 180-182.
15. GERMAIN, R.N., and MARGULIES, D.H. (1993). The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 11, 403-450.
16. GIL, A., and PROUDFOOT, N. (1987). Position-dependent sequence elements downstream of AAUAAA are required for efficient rabbit β-globin mRNA 3′ end formation. Cell 49, 399-406.
17. GINSBERG, H., LUNDHOLM-BEAUCHAMP, U., HORSWOOD, R., PERNIS, B., WOLD, W., CHANOCK, R., and PRINCE, G. (1989). Role of early region 3 (E3) in pathogenesis of adenovirus disease. Proc. Natl. Acad. Sci. USA 86, 3823-3827.
18. GOODING, L., ELMORE, L., TOLLEFSON, A., BRADY, H., and WOLD, W. (1988). A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor. Cell 53, 341-346.
19. GRAHAM, F.L., and PREVEC, L. (1991). Manipulation of adenovirus vector. In Gene Transfer and Expression Protocols. E. J. Murray, ed. (The Humana Press Inc., Clifton, NJ) pp. 109-114.
20. GRAHAM, F.L., SMILEY, J., RUSSEL, W.C., and NAIRN, R. (1977). Characteristics of a human cell line transformed by DNA from human adenovirus 5. J. Gen. Virol. 36, 59-72.
21. GREBER, U.F., WILLETTS, M., WEBSTER, P., and HELENIUS, A. (1993). Stepwise dismantling of adenovirus 2 during entry into cells. Cell 75, 477-486.
22. HAUSER, M.S., PHELPS, S.F., and CHAMBERLAIN, J.S. (1994). Expression of dystrophin minigenes in the muscles of mdx mice partially prevents the development of dystrophic symptoms. Am. J. Hum. Gen. 55, A47.
23. HENDRICKSON, E. (1993). The SCID mouse: Relevance as an animal model system for studying human disease. Am. J. Pathol. 143, 1511-1521.
24. HUARD, J., LOCHMÜLLER, H., ACSADI, G., JANI, A., MASSIE, B., and KARPATI, G. (1995). The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Therapy 2, 107-115.
25. KARPATI, G., and ACSADI, G. (1993). The potential for gene therapy in Duchenne muscular dystrophy and other genetic muscle diseases. Muscle & Nerve 16, 1141-1153.
26. KARPATI, G., and ACSADI, G. (1994). The principles of gene therapy in Duchenne muscular dystrophy. Clin. Invest. Med. 17, 499-509.
27. KARPATI, G., and CURRIE, G.S. (1994). Inflammatory myopathies, in Disorders of Voluntary Muscle. J. Walton, G. Karpati, and D. Hilton-Jones, eds. (Churchill Livingstone, London) pp. 619-646.
28. KARPATI, G., CARPENTER, S., and PRESCOTT, S. (1988a). Small-caliber skeletal muscle fibers do not suffer necrosis in mdx mouse dystrophy. Muscle & Nerve 11, 795-803.
29. KARPATI, G., POULIOT, Y., and CARPENTER, S. (1988b). Expression of immunoreactive major histocompatibility complex products in human skeletal muscles. Ann. Neurol. 23, 64-72.
30. KARPATI, G., CARPENTER, S., MORRIS, G.E., DAVIES, K.E., GUERIN, C., and HOLLAND, P. (1993). Localization and quantitation of the chromosome 6-encoded dystrophin-related protein in normal and pathological human muscle. J. Neuropathol. Exp. Neurol. 52, 119-128.
31. LAMARCHE, N., MASSIE, B., RICHER, M., PARADIS, H., and LANGELIER M. (1990). High level of expression in 293 cells of herpes simplex virus type 2 ribonucleotide reductase subunit 2 using an adenovirus vector. J. Gen. Virol. 71, 1785-1792.
32. LOCHMÜLLER, H., JANI, A., HUARD, J., PRESCOTT, S., SIMONEAU, M., MASSIE, B., KARPATI, G., and ACSADI, G. (1994). Emergence of early region 1 (E1)-containing replication competent adenovirus in stocks of replication defective adenovirus recombinants (ΔE1 + ΔE3) during multiple passages in 293 cells. Hum. Gene Ther. 5, 1485-1491.
33. MANIATIS, T., FRITSCH, E.F., and SAMBROCK, J. (1982). Molecular Cloning: A Laboratory Manual. (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY).
34. + T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J. Virol. 68, 8056-8063.
35. PILEWSKI, J.N., SOTT, D.J., WILSON, J.M., and ALBELDA, S.M. (1995). ICAM-1 expression on bronchial epithelium after recombinant adenovirus infection. Am. J. Respir. Cell Mol. Biol. 12, 142-148.
36. QUANTIN, B., PERRICAUDET, L.D., TAJBAKHSH, S., and MANDEL, J.L. (1990). Adenovirus as an expression vector in muscle cells in vivo. Widespread long-term gene transfer to mouse skeletal muscles and heart via an adenovirus vector. Proc. Natl. Acad. Sci. USA 87, 439-443.
37. RAGOT, T., VINCENT, N., CHAFEY, V., VIGNE, E., GILDENKRANTZ, H., COUTON, D., CARTAUD, J., BRIAND, P., KAPLAN, J-C., PERICAUDET, M., and KAHN, A. (1993). Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 361, 647-650.
38. REED, K.C., and MANN, D.A. (1985). Rapid transfer of DNA from agarose gels to nylon membranes. Nucleic Acids Res. 13, 7207-7221.
39. SCHWARTZ, R.H. (1993). T cell anergy. Sci. Am. 269(2), 62-71.
40. STRATFORD-PERRICAUDET, L.D., MEKAH, I., PERRICAUDET, M., and BRIAND, P. (1992). Widespread long-term gene transfer to mouse skeletal muscles and heart via an adenovirus vector. J. Clin. Invest. 90, 626-630.
41. VINCENT, N., RAGOT, T., GILDENKRANTZ, H., COUTON, D., CHAFEY, P., GREGOIRE, A., BRIAND, P., KAPLAN, J-C., KAHN, A., and PERRICAUDET, M. (1993). Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene. Nature Genet. 5, 130-134.
42. WELLS, D.J., WELLS, K.E., WALSH, F.S., DAVIES, K.E., GOLDSPINK, G., LOVE, D.R., CHAN-THOMAS, P., DUNCKLEY, M.G., PIPER, T., and DICKSON, G. (1992). Human dystrophin expression corrects the myopathic phenotype in transgenic mdx mice. Hum. Mol. Genet. 1, 35-40.
43. WOLD, W.S.M., HERMISTON, T.W., and TOLLEFSON, A.E. (1994). Adenovirus proteins that subvert host defenses. Trends Microbiol. 11, 437-443.
44. WOLFF, J.A., MALONE, R., WILLIAMS, P., CHONG, W., ACSADI, G., JANI, A., and FELGNER, P.L. (1990). Direct gene transfer into mouse muscle in vivo. Science 247, 1465-1468.
45. YANG, Y., RAPER, S., COHN, J., ENGELHARDT, J., and WILSON, J. (1993). An approach for treating hepatobiliary disease of cystic fibrosis by somatic gene transfer. Proc. Natl. Acad. Sci. USA 90, 4601-4605.
46. YANG, Y., NUNES, F.A., BERENCSI, K., FURTH, E.E., GONCZOL, E., and WILSON, J.M. (1994a). Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91, 4407-4411.
47. YANG, Y., NUNES, F., BERENCSI, K., GONCZOL, E., ENGELHARDT, J., and WILSON, J. (1994b). Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nature Genet. 7, 362-369.
48. YANG, Y., LI, Q., ERTL, H.C.J., and WILSON, J.M. (1995). Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69, 2004-2015.